Medicines Manufacturing Innovation Centre - MMIC

Medicines Manufacturing Innovation Centre - MMIC

Research Services

Parkville, Victoria 1,861 followers

Innovative approaches to manufacturing medicines in Victoria.

About us

Based in Parkville and Clayton, Melbourne, the Medicines Manufacturing Innovation Centre is located in the heart of Australia’s word-class biotechnology, medical research and technology precincts. The Medicines Manufacturing Innovation Centre is an initiative between the Victorian State Government and Monash Institute of Pharmaceutical Sciences (MIPS), based on a proven model of success between Monash University and GSK. The Centre has a focus on growing exports of medicines manufactured in Victoria and supports pharmaceutical manufacturers and allied industries by facilitating the optimisation of processes, current and new product development and building supply of highly skilled, industry-ready, workforce candidates. MMIC provides clients with access to world-class infrastructure and a multidisciplinary team to deliver economic impact and competitiveness to the state. Our focus is on ensuring that Victorian manufacturers remain leaders in a global market through collaboration and the use of creative and disruptive innovation. OUR SERVICES MMIC is a growth platform for Victoria’s manufacturing sector that provides opportunities for innovation through specialist analytical and formulation development services, utilising state-of-the art technology and expertise in product development and industrialisation. - Pharmaceutical products - Veterinary products - Medical devices - Complimentary medicines - Nutraceutical - Cosmetics - Personal health care products - Unique Australian capabilities based on a proven track record The MMIC offers access a flexible an agile team of experienced industrial scientists who are highly skilled in analytical chemistry, method development and validation, formulation, process optimisation, product development and industrialisation.

Website
http://monash.edu/mmic
Industry
Research Services
Company size
11-50 employees
Headquarters
Parkville, Victoria
Type
Educational
Founded
2017
Specialties
Analytical characterisation, Formulation, Oral solid dose forms, Aerosol dose Forms, Industrialisation, Manufacturing, Innovation, Medicines, Blow fill seal, Pharmaceutical, Veterinary, Medical devices, Nutiaceuticals, HPLC/UHPLC, GC/LC-MS, Freeze drying, Milling and mixing, Mechanofusion, Consulting, Contract research, Ultra sonication, Spray drying, Mechanofusion, Granulation, Powder and materials testing, XRD, DSC, TGA Characterisation, Colloidal & dispersed systems, Aqueous and lipid systems, BFS sterile aqueous liquids, Oral inhalers and nasal spray, Powders & granules, Tablets, capsules, Product development, and Victorian biotech

Locations

Employees at Medicines Manufacturing Innovation Centre - MMIC

Updates

  • It is very positive to see CSL expanding their operations in Melbourne both for the company and for the future health of the sector and all people in the Australian region. We look forward to continuing to support our friends and colleagues at CSL to continue innovating, manufacturing, and preparing us for the future.

    View organization page for CSL, graphic

    246,451 followers

    What do you get when you bring together three experts in public health, vaccines, and manufacturing and add a new vaccine manufacturing site? Some terrific conversations about influenza, pandemic preparedness, and CSL’s technical capabilities in Australia. We welcomed the Australian Government Department of Health and Aged Care's Chief Medical Officer and Head of the interim Australian CDC, Professor Paul Kelly to the CSL Seqirus Tullamarine facility that will provide onshore production capacity for antivenoms for Australia and cell-based influenza vaccines for Australia and the world. #CSL #CSLSeqirus #Tullamarine #Australia #publichealth #vaccines #influenza #DrivenByOurPromise

    • No alternative text description for this image
    • No alternative text description for this image
  • Congratulations to Russell Hayward, ganesh raj and the whole etiraRx team. We have had the pleasure of working with ERX-315 on its journey across the rickety bridge over the "Valley of Death". In any good story, there are always a few more experiments and a few more problems to solve but this one is a thriller that promises an exciting finale.

    View organization page for etiraRx, graphic

    485 followers

    ERX-315 CLINICAL TRIAL APPROVED BY HREC Etira is pleased to announce the approval of the ERX-315 Phase 1 clinical trial by the Australian Human Research Ethics Committee (HREC). This HREC approval enables the start of the clinical trial titled "A Phase 1 Trial of ERX-315 in Participants with Advanced Solid Tumors” The trial will begin to recruit patients at The Kinghorn Cancer Centre in Sydney and be overseen by the overall trial principal investigator, Dr. Rasha Cosman, the Head of Early Phase Clinical Trials Unit and the Clinical Lead of Oncology Clinical Trials at the Kinghorn Cancer Center.  The trial will evaluate the safety and tolerability of ERX-315 in in patients with advanced solid tumors, who have progressed on prior approved systemic therapies. ERX-315 is designed to target specific pathways that are critical for cancer cell survival and proliferation. This targeted approach helps to spare healthy cells, potentially reducing side effects commonly associated with cancer therapies. Interested individuals can learn more about the trial, eligibility criteria, and how to participate by visiting the link below: https://lnkd.in/ginG-Ewz Etira will provide updates on the continued progress of the ERX-315 clinical trial and activation in additional clinical trial sites in Australia. This clinical trial represents a significant step forward in Etira’s pursuit of effective treatments for patients with metastatic therapy-resistant cancers. 

    • No alternative text description for this image
  • El Centro de Innovación en Fabricación de Medicamentos (MMIC) trabaja con innovadores de todo el mundo para desarrollar formulaciones para nuevos compuestos o para la reutilización de medicamentos existentes. La formulación es a menudo una de las partes menos interesantes de la historia de la innovación, pero es vital para trasladar el descubrimiento a la clínica o la fabricación GMP. La atractiva configuración fiscal de I D y el entorno de ensayos clínicos hacen de Melbourne un destino atractivo para todos los innovadores en el espacio farmacéutico. Please feel welcome to reach out to the Medicines Manufacturing Innovation Centre - MMIC team. Monash Institute of Pharmaceutical Sciences Invest Victoria Global Victoria Department of Jobs, Skills, Industry and Regions #innovation #pharmaceutical #manufacturing

    🌟 ¡El Medicines Manufacturing Innovation Centre - MMIC ha abierto en Monash university consolidando a #Melbourne como líder en investigación y manufactura médica! 💰 Con más de $16 millones en inversión gubernamental, esta instalación de última generación acelerará el desarrollo de tratamientos que salvan vidas. 🧪 El Medicines Manufacturing Innovation Centre - MMIC ya está haciendo historia con una subvención del the Cumming Global Centre for Pandemic Therapeutics, trabajando en un nuevo antiviral para virus respiratorios. 🔬 Este es solo uno de los muchos centros de innovación en #Melbourne, impulsado por tecnología de punta e infraestructura de primer nivel. Conoce más sobre este: https://lnkd.in/g6Zriyt9 #ThinkMelbourne #MedTech #Innovación Monash University

    • No alternative text description for this image
  • We were pleased to welcome colleagues from Shimadzu Scientific Australasia on a visit to the Medicines Manufacturing Innovation Centre - MMIC's new laboratory based at the ANSTO Australian Synchrotron in #Melbourne last week. Shimadzu has been a supporter of analytical science at the MMIC and in our sister laboratory, the HMSTrust Analytical Chemistry laboratory at Monash Institute of Pharmaceutical Sciences, for many years. The relationship remains an excellent demonstration of how collaboration around technology can drive innovation through an entire sector and into surrounding space. Clayton Ross Nigel Grieves Hung Luu Rudi Hollander SHIMADZU CORPORATION Monash Institute of Pharmaceutical Sciences Department of Jobs, Skills, Industry and Regions

    • No alternative text description for this image
  • #Melbourne is also our home and an amazing place to discover new science and technology, to advance pharmaceutical science, medtech, materials science, and health. The Medicines Manufacturing Innovation Centre - MMIC is proud of our team and facilities but more enthusiastic about the success of our clients. Feel welcome to make contact and perhaps enjoy the Melbourne experience. Monash Institute of Pharmaceutical Sciences Department of Jobs, Skills, Industry and Regions #thinkMelbourne #pharmaceuticals #Innovation

    View organization page for Invest Victoria, graphic

    12,201 followers

    𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐚 𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐝𝐞𝐬𝐭𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐲𝐨𝐮𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬? 𝐓𝐡𝐢𝐧𝐤 #Melbourne, 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚. 𝐖𝐢𝐭𝐡 𝐕𝐢𝐜𝐭𝐨𝐫𝐢𝐚'𝐬 𝐩𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐠𝐫𝐨𝐰𝐭𝐡 𝐚𝐧𝐝 𝐬𝐭𝐫𝐨𝐧𝐠 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐨𝐮𝐭𝐥𝐨𝐨𝐤, 𝐢𝐭 𝐦𝐚𝐤𝐞𝐬 𝐚 𝐜𝐨𝐦𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐜𝐡𝐨𝐢𝐜𝐞. Victoria's population is growing! 📈 The Victoria in Future 2023 report covers the period 2023 to 2051 for Melbourne and the major regions, and provides valuable insights into the state's projected growth trends. 𝐊𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 📊 Victoria's population is projected to grow significantly over the next few decades, outpacing other Australian states and territories. 📊 Factors such as rising birth rates, increasing life expectancy, and continued migration are contributing to this growth. 📊 The number of households is also set to rise, indicating a growing demand for housing and related services. 📊 Both Greater Melbourne and the regional areas are expected to experience substantial population increases, suggesting diverse investment opportunities. Discover why now is the time to invest in Melbourne, Australia. Download the full report here: https://lnkd.in/gBguicEq #ThinkMelbourne

    • No alternative text description for this image
  • These two photos say a lot about the invaluable breadth of Paul Wynne's contributions to the MMIC. The photo on the left was taken at the very start in 2017, with optimism and extensive planning to set up this new innovation centre. Fast forward over seven years, and Paul stands at the entrance of a new, purpose-built facility at the Australian Synchrotron, expanding our footprint across two facilities at Parkville to Clayton. Although there have been many more achievements and milestones in the intervening years, Paul’s vision and dedication in shaping the MMIC have been instrumental to what it is today. His commitment to mentoring and developing our experienced team of subject matter experts in formulation, analytical and synthetic chemistry, respiratory delivery and biological therapeutics has allowed the MMIC to flourish. It has provided us with a strong foundation for continued growth. Beyond his contributions to our team, Paul has also been a key figure in fostering relationships with companies across Australia and internationally. These collaborations have ensured that MMIC continues supporting our clients with advanced problem-solving and research and development support. Through these partnerships, the Centre has contributed to the formulation of nine products that have advanced into clinical trials, been listed as inventors on multiple patents, and supported job creation in the Victorian pharmaceutical and medtech sectors, including manufacturing, clinical trials, and research institutes. Many past students participating in our internship program have also attested to Paul's patience and wise words in guiding them to discern the career opportunities that lie ahead. While Paul’s departure marks the end of an era, we are inspired by his unwavering commitment, leadership, and support over the years. We wish him the very best in his future endeavours and hope to continue building on the strong foundation he has laid for us.

    • No alternative text description for this image
  • Medicines Manufacturing Innovation Centre - MMIC reposted this

    Summer internship applications are now open for 2024/2025 MMIC Internship Program. Through the summer internship program, the MMIC is committed to mentoring and supporting the next generation of scientists, providing a comprehensive learning experience, and empowering students with the knowledge and skills relevant to the sector. Over a 8-10 week period, our summer interns will work on industry-based projects and participate in professional and technical development workshops. Applicants should have prior experience or are currently enrolled in a relevant degree in pharmaceutical science, chemical engineering, physical chemistry, analytical chemistry or biotechnology Apply here: https://lnkd.in/gAU4buiy

    • No alternative text description for this image
  • The Medicines Manufacturing Innovation Centre - MMIC has welcomed some amazing clients and equally brilliant projects into our laboratories over the past few years. In a crowded gallery, etiraRx's ERX-315 is a favourite for the clever design and the challenges this brilliant molecule threw at the team to overcome, but more importantly for its promise to future generations of cancer patients. In true Australian style, the etiraRx team are now more than just clients - they are friends and colleagues and their continuing success is a part of our mission. Department of Jobs, Skills, Industry and Regions Monash Institute of Pharmaceutical Sciences Invest Victoria

    View organization page for etiraRx, graphic

    485 followers

    Etira’s Australian partner MMIC expands!   We congratulate Etira’s Australian partner Medicines Manufacturing Innovation Centre (MMIC) for their recent expansion which will enable further opportunities for innovation across medicine formulation, and resolving manufacturing process challenges   MMIC was an invaluable partner to Etira in defining the manufacturing process and working through formulation challenges and enabling the clinical transition of ERX-315. We will be forever linked to MMIC, especially Dr. Paul Wynne and his team, for their insightful, inspired and superb commitment to our project!   For further details of this expansion, please see https://lnkd.in/gvZ67mrk

    • No alternative text description for this image
  • Summer internship applications are now open for 2024/2025 MMIC Internship Program. Through the summer internship program, the MMIC is committed to mentoring and supporting the next generation of scientists, providing a comprehensive learning experience, and empowering students with the knowledge and skills relevant to the sector. Over a 8-10 week period, our summer interns will work on industry-based projects and participate in professional and technical development workshops. Applicants should have prior experience or are currently enrolled in a relevant degree in pharmaceutical science, chemical engineering, physical chemistry, analytical chemistry or biotechnology Apply here: https://lnkd.in/gAU4buiy

    • No alternative text description for this image
  • Thank you to the Labconco and John Morris team for helping us commission our new Triad freeze-dryer at our recently opened Clayton facility. The new system will enhance our existing freeze-drying capabilities with advanced temperature controls and in-situ vial capping features. Using this new tool, the MMIC team aims to develop advanced, scalable formulations to stabilise and deliver new and emerging biological therapeutics for our industry clients and institutional partners.

    View organization page for John Morris Group, graphic

    6,160 followers

    Another fantastic stop on our #Labconco tour! Nathan Richardson from Labconco Corporation joined our team members Ozlem Alizart and Daniel Wan at the Australian Synchrotron/MMIC (Monash University Medicines Manufacturing Innovation Centre - MMIC) to train their team on the new Labconco Triad. A big thanks to Nathan for the insightful training session! Stay tuned for more updates from our #Labconco tour. #LabconcoTour #Innovation #Training #Synchrotron #MonashUniversity #JohnMorrisGroup

    • No alternative text description for this image
    • No alternative text description for this image

Similar pages

Browse jobs